Clinical Trials Browser

Leukemia, Myeloid, Acute × Homoharringtonine × 30 days × Clear all

NCT07469046 2026-03-13

VAH vs VA in Newly Diagnosed Elderly AML

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06483906 2026-03-03

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute